Barclays Maintains Equal-Weight on Tyler Technologies, Lowers Price Target to $370
Barclays analyst Saket Kalia maintains Tyler Technologies (NYSE:TYL) with a Equal-Weight and lowers the price target from $445 to $370.
Barclays Maintains Equal-Weight on Varonis Systems, Lowers Price Target to $36
Barclays analyst Saket Kalia maintains Varonis Systems (NASDAQ:VRNS) with a Equal-Weight and lowers the price target from $46 to $36.
HC Wainwright & Co. Maintains Buy on Syros Pharmaceuticals, Lowers Price Target to $6
HC Wainwright & Co. analyst Andrew Fein maintains Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and lowers the price target from $10 to $6.
JP Morgan Downgrades Lennar to Neutral, Lowers Price Target to $80
JP Morgan analyst Michael Rehaut downgrades Lennar (NYSE:LEN) from Overweight to Neutral and lowers the price target from $83 to $80.
Goldman Sachs Initiates Coverage On MultiPlan with Neutral Rating, Announces Price Target of $6.5
Goldman Sachs analyst Cindy Motz initiates coverage on MultiPlan (NYSE:MPLN) with a Neutral rating and announces Price Target of $6.5.
Goldman Sachs Maintains Buy on JD.com, Lowers Price Target to $89
Goldman Sachs analyst Ronald Keung maintains JD.com (NASDAQ:JD) with a Buy and lowers the price target from $98 to $89.
Needham Maintains Buy on CryoPort, Raises Price Target to $42
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $41 to $42.
Piper Sandler Initiates Coverage On Zoetis with Overweight Rating, Announces Price Target of $205
Piper Sandler analyst David Westenberg initiates coverage on Zoetis (NYSE:ZTS) with a Overweight rating and announces Price Target of $205.
Raymond James Initiates Coverage On Avidity Biosciences with Strong Buy Rating, Announces Price Target of $29
Raymond James analyst Steven Seedhouse initiates coverage on Avidity Biosciences (NASDAQ:RNA) with a Strong Buy rating and announces Price Target of $29.
Rosenblatt Initiates Coverage On Avid Technology with Neutral Rating, Announces Price Target of $30
Rosenblatt analyst Steve Frankel initiates coverage on Avid Technology (NASDAQ:AVID) with a Neutral rating and announces Price Target of $30.